Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Suzetrigine for Opioid-Sparing Postoperative Analgesia Following Transvaginal Pelvic Reconstructive Surgery

NCT07600697 is registered in ClinicalTrials.gov with University of California, Los Angeles as lead sponsor.

NCT NCT07600697
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07600697 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Suzetrigine for Opioid-Sparing Postoperative Analgesia Following Transvaginal Pelvic Reconstructive Surgery
Lead sponsor
University of California, Los Angeles
Phase
Phase 4
Overall status
Not yet recruiting
Start date
November 1, 2026
Completion date
July 1, 2028
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pelvic organ prolapse (pop), postoperative pain, stress urinary incontinence (sui)